Sales 2024 * | 48.09B 44.62B | Sales 2025 * | 50.12B 46.51B | Capitalization | 212B 197B |
---|---|---|---|---|---|
Net income 2024 * | 10.05B 9.32B | Net income 2025 * | 11.03B 10.24B | EV / Sales 2024 * | 4.66 x |
Net Debt 2024 * | 11.49B 10.67B | Net Debt 2025 * | 9.56B 8.87B | EV / Sales 2025 * | 4.43 x |
P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
16.7
x | Employees | 76,057 |
Yield 2024 * |
3.84% | Yield 2025 * |
3.96% | Free-Float | 81.95% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B | |
-1.28% | 152B |